Orange Book product · Generic (ANDA)
DOBUTAMINE HYDROCHLORIDE
DOBUTAMINE HYDROCHLORIDE
At a glance
Nov 29, 1993
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 29, 1993
33 yr ago
Today
Pharmaceutical detail
Active ingredient
DOBUTAMINE HYDROCHLORIDE
Strength
EQ 12.5MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 074086
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of DOBUTAMINE HYDROCHLORIDE
- 1993DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%Brand (NDA)
NDA 020269 · HOSPIRA
- 1993DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 020255 · BAXTER HLTHCARE
- 1993DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 020201 · HOSPIRA
- —DOBUTREXBrand (NDA)
NDA 017820 · LILLY
- 2022DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216131 · SLATE RUN PHARMA
- 1998DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074545 · LUITPOLD
- 1998DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074995 · DR REDDYS
- 1998DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074279 · WATSON LABS INC
- 1996DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074634 · HOSPIRA
- 1996DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074381 · BAXTER HLTHCARE
- 1995DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074098 · TELIGENT
- 1995DOBUTAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074292 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
